121 related articles for article (PubMed ID: 2813805)
1. Long term treatment with oxaprotiline in patients with major depression.
Katz RJ
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):875-83. PubMed ID: 2813805
[TBL] [Abstract][Full Text] [Related]
2. Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trial.
Schmauss M; Laakmann G; Dieterle D; Blaschke D
Pharmacopsychiatry; 1985 Jul; 18(4):282-5. PubMed ID: 3895255
[TBL] [Abstract][Full Text] [Related]
3. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G
Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439
[TBL] [Abstract][Full Text] [Related]
4. CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study.
Wolfersdorf M; Wendt G; Binz U; Steiner B; Hole G
Pharmacopsychiatry; 1988 Jul; 21(4):203-7. PubMed ID: 3060885
[TBL] [Abstract][Full Text] [Related]
5. [The Eppendorf Mood and Motivation Scale as assessment procedure in the clinical evaluation of an antidepressive agent].
Binz U; Wendt G
Fortschr Med; 1982 Dec; 100(45):2111-7. PubMed ID: 6757074
[No Abstract] [Full Text] [Related]
6. Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives.
Emrich HM; Berger M; Riemann D; von Zerssen D
Pharmacopsychiatry; 1987 Mar; 20(2):60-3. PubMed ID: 3108909
[TBL] [Abstract][Full Text] [Related]
7. [Further clinical experiences with maprotiline in endogeneous depressions].
Náhunek K; Svestka J; Rysánek R; Cesková E
Act Nerv Super (Praha); 1982 May; 24(2):81-7. PubMed ID: 7048835
[No Abstract] [Full Text] [Related]
8. Comparative study of levoprotiline and amitriptyline in endogenous depressions.
Faltus F; Molcan J; Svestka J; Náhunek K; Mrna B; Zapletálek M; Krekule P; Janecková E; Koníková M; Pazdírek S
Act Nerv Super (Praha); 1989 Dec; 31(4):279-80. PubMed ID: 2638109
[No Abstract] [Full Text] [Related]
9. Differential effects of the enantiomers R(-) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: studies on depressed patients and normal controls.
Steiger A; Gerken A; Benkert O; Holsboer F
Eur Neuropsychopharmacol; 1993 Jun; 3(2):117-26. PubMed ID: 8364347
[TBL] [Abstract][Full Text] [Related]
10. [Psychometric findings in treatment using the selective MAO-A inhibitors moclobemide and maprotiline].
Classen W
Psychiatr Prax; 1989 Aug; 16 Suppl 1():41-3. PubMed ID: 2587675
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
Gwirtsman HE; Ahles S; Halaris A; DeMet E; Hill MA
J Clin Psychiatry; 1983 Dec; 44(12):449-53. PubMed ID: 6361005
[TBL] [Abstract][Full Text] [Related]
12. Maprotiline in affective illness. Plasma concentration and clinical response.
Norman TR; Burrows GD; Maguire KP; McIntyre IM; Scoggins BA
J Affect Disord; 1983 May; 5(2):147-54. PubMed ID: 6222094
[TBL] [Abstract][Full Text] [Related]
13. Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levels.
Giedke H; Gaertner H; Breyer-Pfaff U; Rein W; Axmann D
Eur Arch Psychiatry Neurol Sci; 1986; 235(6):329-38. PubMed ID: 3527706
[TBL] [Abstract][Full Text] [Related]
14. Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders.
Poelinger W; Haber H
Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():47-50. PubMed ID: 2644340
[No Abstract] [Full Text] [Related]
15. Maprotiline (Ludiomil, Ciba 34,276-BA) and imipramine in depressed outpatients: a double-blind clinical study.
Singh AN; Saxena B; Gent M; Nelson HL
Curr Ther Res Clin Exp; 1976 Apr; 19(4):451-62. PubMed ID: 816603
[No Abstract] [Full Text] [Related]
16. [The effect of maprotiline on target symptoms of depressive states].
Faltus F
Act Nerv Super (Praha); 1982 May; 24(2):99-100. PubMed ID: 7102230
[No Abstract] [Full Text] [Related]
17. Zimelidine vs maprotiline in depressed outpatients. A preliminary report.
d'Elia G; Hällström T; Nyström C; Ottosson JO
Acta Psychiatr Scand Suppl; 1981; 290():225-35. PubMed ID: 6452793
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with maprotiline.
Kabes J; Dostal T; Roth Z
Act Nerv Super (Praha); 1982 May; 24(2):93-8. PubMed ID: 7048837
[No Abstract] [Full Text] [Related]
19. [Changes in slow evoked potentials in depressed patients treated with amitriptyline and oxaprotiline].
Giedke H; Heimann H; Rein W
Rev Electroencephalogr Neurophysiol Clin; 1987 Sep; 17(3):279-87. PubMed ID: 3685573
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant plasma levels and clinical response in depressed patients treated with oxaprotiline and doxepin.
Hrdina PD; Lapierre YD; Horn E; Bakish D; Browne M
Int Clin Psychopharmacol; 1988 Jul; 3(3):205-14. PubMed ID: 3153709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
